# Exhaustive Enrichment Status

**Started:** 2025-11-16 05:14:39
**Database:** data/bayarea_biotech_sources.db
**Total Companies:** 2,491

## Overview

Running exhaustive enrichment on ALL companies in the database using two APIs:
1. **SEC EDGAR** - Identifies public companies through SEC filings
2. **ClinicalTrials.gov** - Identifies clinical-stage companies through trial sponsorship

## Current Progress (as of 2025-11-16 08:36)

### Overall Statistics
- **Total companies:** 2,491
- **Classified:** 632 (25.4%)
- **Unclassified:** 1,859 (74.6%)

### Data Sources
- **Companies with SEC data:** 682
- **Companies with clinical trials:** 169

### Classification Breakdown
- **Public:** 471 (18.9%)
- **Clinical Stage:** 103 (4.1%)
- **Public/Late-Stage:** 58 (2.3%)

### Progress Since Start
- **Starting classified:** 374 (15.0%)
- **Newly classified:** 258 companies
- **Improvement:** 10.4 percentage points (from 15.0% to 25.4%)

## API Progress

### ClinicalTrials.gov API
- **Status:** Running ✓
- **Progress:** 340/2,483 companies (13.7%)
- **Success rate:** 100%
- **Findings:** 165 new companies with clinical trials
- **Estimated completion:** 2-3 hours

### SEC EDGAR API
- **Status:** Running in parallel ✓
- **Success rate:** 78.6%
- **Findings:** 265 new companies with SEC data

## Issues Fixed

### 1. ClinicalTrials API v2 Query Parameters ✓
**Problem:** API was returning 400 Bad Request errors
**Solution:**
- Changed from comma-separated fields to pipe-separated format
- Fixed query parameter from `query.spons` to correct v2 API syntax
- Increased pageSize from 100 to 1000 (v2 allows larger page sizes)

### 2. Stage Classification Logic ✓
**Problem:** Classification was returning "Unknown" for all trials
**Solution:**
- Fixed phase name normalization (API returns "PHASE1", "PHASE2", not "Phase 1", "Phase 2")
- Added robust phase parsing to handle variations
- Normalized status values to handle both formats

### 3. Database Schema Adaptation ✓
**Problem:** Code was using non-existent `classification` column
**Solution:**
- Updated to use `company_classifications` table with `company_stage` column
- Implemented proper `is_current` flag filtering
- Fixed all queries to use thread-safe `connection` property

## Next Steps

1. **Monitor Progress:** Continue running until all 2,491 companies are processed
2. **Generate Final Report:** Script will automatically generate comprehensive report upon completion
3. **Analyze Results:** Review classification improvements and data quality

## Monitoring

To check current progress:
```bash
python3 scripts/enrichment/monitor_enrichment.py --once
```

To continuously monitor (updates every 60 seconds):
```bash
python3 scripts/enrichment/monitor_enrichment.py
```

## Expected Outcomes

Based on current progress:
- **Final classified companies:** Estimated 800-1,000 (32-40%)
- **Reduction in unclassified:** From 85% to ~60-65%
- **Clinical stage companies:** Estimated 200-300
- **Public companies:** Estimated 500-600

## Files Created/Modified

### Fixed Files
- `/mnt/c/Users/shirk/Documents/Adulting/EastBayBiotechMap/scripts/enrichment/clinicaltrials_client.py`

### New Files
- `/mnt/c/Users/shirk/Documents/Adulting/EastBayBiotechMap/scripts/enrichment/run_exhaustive_enrichment.py`
- `/mnt/c/Users/shirk/Documents/Adulting/EastBayBiotechMap/scripts/enrichment/monitor_enrichment.py`
- `/mnt/c/Users/shirk/Documents/Adulting/EastBayBiotechMap/scripts/enrichment/test_clinicaltrials_fix.py`

### Log Files
- `logs/ct_enrichment_live.log` - Live progress log
- `logs/enrichment_report_*.txt` - Final report (generated upon completion)
